MAIN APPLICATION
Applications
HIGHLIGHTS
HA Concentration | 22 mg/ml |
Lidocaine | 0.3% |
Composition | Cross-linked HA |
Treated Areas & Indications | Volume recovery for wide areas (face oval, cheeks, temples) |
Injection Depth | Subcutaneous and/or pre- periosteum |
Box | 2×1.2mL/Needle: 25G1 |
Estimated Duration | 12 months |